Michael E. Ray

2.5k total citations
35 papers, 1.9k citations indexed

About

Michael E. Ray is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Molecular Biology. According to data from OpenAlex, Michael E. Ray has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 9 papers in Molecular Biology. Recurrent topics in Michael E. Ray's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Advanced Radiotherapy Techniques (10 papers). Michael E. Ray is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Advanced Radiotherapy Techniques (10 papers). Michael E. Ray collaborates with scholars based in United States, Canada and Australia. Michael E. Ray's co-authors include Jeffrey M. Trent, Paul S. Meltzer, Yan Su, Howard M. Sandler, James D. Murphy, Stephen P. Ethier, Zeng Quan Yang, Kent A. Griffith, Ricky W. Johnstone and Sarah L. Anzick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Michael E. Ray

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Ray United States	23	946	626	440	382	271	35	1.9k
Akash Nanda United States	14	651 0.7×	624 1.0×	275 0.6×	269 0.7×	216 0.8×	24	1.5k
J. Doyen France	22	661 0.7×	520 0.8×	716 1.6×	253 0.7×	617 2.3×	101	1.9k
Tony Elliott United Kingdom	22	736 0.8×	326 0.5×	503 1.1×	122 0.3×	213 0.8×	58	1.6k
Kent W. Mouw United States	25	860 0.9×	982 1.6×	995 2.3×	148 0.4×	617 2.3×	117	2.6k
Julian D. Down United States	23	471 0.5×	532 0.8×	295 0.7×	145 0.4×	314 1.2×	50	2.0k
David Clouston Australia	20	557 0.6×	453 0.7×	279 0.6×	53 0.1×	202 0.7×	49	1.3k
Yungan Tao France	27	660 0.7×	586 0.9×	1.0k 2.3×	91 0.2×	248 0.9×	112	2.3k
Douglas B. Einstein United States	18	493 0.5×	292 0.5×	354 0.8×	297 0.8×	94 0.3×	28	1.4k
Peter M.L. Teo China	24	1.1k 1.2×	471 0.8×	978 2.2×	494 1.3×	347 1.3×	34	2.9k
Deirdre Jill Cohen United States	23	436 0.5×	327 0.5×	741 1.7×	131 0.3×	300 1.1×	96	1.7k

Countries citing papers authored by Michael E. Ray

Since Specialization

Citations

This map shows the geographic impact of Michael E. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Ray more than expected).

Fields of papers citing papers by Michael E. Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Ray. The network helps show where Michael E. Ray may publish in the future.

Co-authorship network of co-authors of Michael E. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Ray. A scholar is included among the top collaborators of Michael E. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Ray. Michael E. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Scott C., Karen E. Hoffman, D.A. Loblaw, et al.. (2018). Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. Practical Radiation Oncology. 8(6). 354–360. 159 indexed citations

Morgan, Scott C., Karen E. Hoffman, D.A. Loblaw, et al.. (2018). Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. Journal of Clinical Oncology. 36(34). 3411–3430. 129 indexed citations

Kapoor, Rishabh, Drew Moghanaki, Michael E. Ray, et al.. (2018). Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR. Journal of the American College of Radiology. 15(12). 1732–1737. 2 indexed citations

Jackson, Will, Felix Y. Feng, Stephanie Daignault, et al.. (2015). A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy. Advances in Radiation Oncology. 1(1). 59–66. 3 indexed citations

Vainshtein, Jeffrey M., Eyad Abu‐Isa, Karin Olson, et al.. (2012). Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiation Oncology. 7(1). 82–82. 42 indexed citations

Sabolch, Aaron, Mary Feng, Kent A. Griffith, et al.. (2011). Risk Factors for Local Recurrence and Metastasis in Soft Tissue Sarcomas of the Extremity. American Journal of Clinical Oncology. 35(2). 151–157. 52 indexed citations

Murphy, James D., et al.. (2009). Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature. Clinical Cancer Research. 15(2). 589–596. 40 indexed citations

Ignatoski, Kathleen M. Woods, Sonja M. Markwart, Adaikkalam Vellaichamy, et al.. (2008). Loss of Raf Kinase Inhibitory Protein Induces Radioresistance in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). 153–160. 40 indexed citations

Murphy, James D., et al.. (2008). Gemcitabine-Mediated Radiosensitization of Human Soft Tissue Sarcoma. Translational Oncology. 1(1). 50–56. 13 indexed citations

10.

Feng, Mary, James D. Murphy, Kent A. Griffith, et al.. (2007). Long-Term Outcomes After Radiotherapy for Retroperitoneal and Deep Truncal Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 69(1). 103–110. 41 indexed citations

11.

Murphy, James D., Saroja Adusumilli, Kent A. Griffith, et al.. (2007). Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 68(3). 801–808. 148 indexed citations

12.

Lin, Alexander J. & Michael E. Ray. (2006). Targeted and systemic radiotherapy in the treatment of bone metastasis. Cancer and Metastasis Reviews. 25(4). 669–675. 37 indexed citations

13.

Ray, Michael E., Larry B. Levy, Eric M. Horwitz, et al.. (2006). Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. Urology. 68(6). 1257–1262. 23 indexed citations

14.

Ray, Michael E., Kirk J. Wojno, Neal S. Goldstein, et al.. (2006). Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. Urology. 67(2). 423.e5–423.e8. 17 indexed citations

15.

Ray, Michael E., Rohit Mehra, Howard M. Sandler, Stephanie Daignault, & Rajal B. Shah. (2006). E-Cadherin Protein Expression Predicts Prostate Cancer Salvage Radiotherapy Outcomes. The Journal of Urology. 176(4). 1409–1414. 22 indexed citations

16.

Ray, Michael E., Howard D. Thames, Larry B. Levy, et al.. (2005). PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1140–1150. 140 indexed citations

17.

Ray, Michael E., Rodney L. Dunn, Kathleen A. Cooney, & Howard M. Sandler. (2003). Family history of prostate cancer and relapse after definitive external beam radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 57(2). 371–376. 9 indexed citations

18.

Teichmann, Ulrike, Michael E. Ray, Jane Ellison, et al.. (1998). Cloning and tissue expression of the mouse ortholog of AIM1, a βγ-crystallin superfamily member. Mammalian Genome. 9(9). 715–720. 16 indexed citations

19.

Ray, Michael E., Yan Su, Sarah L. Anzick, et al.. (1997). Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene. 15(4). 453–457. 227 indexed citations

20.

Ray, Michael E., Graeme Wistow, Yan Su, Paul S. Meltzer, & Jeffrey M. Trent. (1997). AIM1 , a novel non-lens member of the βγ-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proceedings of the National Academy of Sciences. 94(7). 3229–3234. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact